Clinical pathways, guidelines, and guidance for FeNO

Developed by Wessex AHSN, here you can find useful links to FeNO Guidance for the diagnosis and treatment of asthma

NICE guidance is integral to the clinical care that we offer as Health Care Professionals (HCPs). It is important to consider the evidence bases for all pathways, tests and procedures that we undertake.

NICE has produced an interactive pathway on their website to guide clinical teams, along with comprehensive guidance on the diagnosis and treatment of asthma. It is important to familiarise ourselves with this work prior to any clinical development projects.

In November 2017, NICE published Asthma: diagnosis, monitoring and chronic asthma management (NG80). In this clinical guideline, FeNO is recommended for use in the diagnosis of asthma in adults and for consideration in certain children over 5 years old. You can review the wider NICE pages on Asthma diagnosis by visiting the NICE website: https://cks.nice.org.uk/topics/asthma/diagnosis/diagnosis/

NICE has also provided resources and tools that complement their Asthma Guidelines.

For specific guidance on use of FeNO in diagnosis of asthma you can review NICE Diagnostic Guidance 12 (DG12 - Measuring fractional exhaled nitric oxide concentration in asthma)

The NHS England/Improvement South West Respiratory Clinical Network has developed a pragmatic guide for those introducing the use of FeNO to their practice.

Please note the Wessex AHSN FeNO programme does not endorse this guide, but is sharing it as one example of a guide for others considering a similar document.
Thank you to the NHSEI South West Respiratory Clinical Network for sharing this example of their work.

The AHSN Network supported the spread of FeNO testing across primary care in England from April 2021 to March 2023, led by Wessex AHSN as the lead AHSN. This programme was delivered as part of the NHS England Accelerated Access Collaborative Rapid Uptake Programme. The resources created as part of that programme have been shared with the PCRS to host as a legacy of the programme. We’d like to express our thanks to Wessex AHSN for sharing these resources with us.

Attachment	Size
A pragmatic guide for those introducing the use of FeNO to their practice (South West Respiratory Clinical Network)	467.34 KB

Clinical Area

Respiratory tests and investigations

FeNO

The fractional exhaled nitric oxide (FeNO) test measures the level of NO in the exhaled breath and provides an indication of eosinophilic inflammation in the lungs.

FeNO for the diagnosis and management of asthma

Resources from the Academic Health Science Network (AHSN) Programme

Clinical pathways, guidelines, and guidance for FeNO

Please note the Wessex AHSN FeNO programme does not endorse this guide, but is sharing it as one example of a guide for others considering a similar document. Thank you to the NHSEI South West Respiratory Clinical Network for sharing this example of their work.

FeNO

FeNO for the diagnosis and management of asthma

Please note the Wessex AHSN FeNO programme does not endorse this guide, but is sharing it as one example of a guide for others considering a similar document.
Thank you to the NHSEI South West Respiratory Clinical Network for sharing this example of their work.